Total Payments
$57,223
2023 Payments
$80.47
Companies
21
Transactions
265
Medicare Patients
3,575
Medicare Billing
$392,073
Payment Breakdown by Category
Other$49,089 (85.8%)
Food & Beverage$5,407 (9.4%)
Travel$2,522 (4.4%)
Education$204.97 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49,089 | 22 | 85.8% |
| Food and Beverage | $5,407 | 217 | 9.4% |
| Travel and Lodging | $2,522 | 23 | 4.4% |
| Education | $204.97 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $21,727 | 44 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $18,643 | 45 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $14,089 | 28 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $766.35 | 54 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $393.51 | 19 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $291.05 | 15 | $0 (2017) |
| PFIZER INC. | $253.08 | 19 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $241.83 | 13 | $0 (2018) |
| Astellas Pharma US Inc | $239.43 | 4 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $152.52 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $80.47 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($80.47) |
| 2021 | $125.00 | 1 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2019 | $11,724 | 25 | SANOFI-AVENTIS U.S. LLC ($5,409) |
| 2018 | $18,548 | 31 | Regeneron Healthcare Solutions, Inc. ($8,118) |
| 2017 | $26,746 | 207 | Amgen Inc. ($11,480) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $80.47 | General |
| Category: Cardio-renal | ||||||
| 06/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/03/2019 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: Cardiology | ||||||
| 11/03/2019 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $18.56 | General |
| Category: Cardiology | ||||||
| 11/03/2019 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Cardiology | ||||||
| 10/24/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $105.85 | General |
| Category: Cardiology | ||||||
| 09/16/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,910.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Travel and Lodging | Cash or cash equivalent | $49.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/01/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,303.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/01/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/01/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Travel and Lodging | Cash or cash equivalent | $6.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/25/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Travel and Lodging | In-kind items and services | $192.66 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/25/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $134.34 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/25/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $58.47 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/25/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $55.03 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/25/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $43.02 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/25/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $36.96 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/25/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $30.51 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/12/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Travel and Lodging | In-kind items and services | $56.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/12/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/12/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 05/23/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,910.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 04/10/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Travel and Lodging | In-kind items and services | $218.14 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 04/10/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Travel and Lodging | In-kind items and services | $138.76 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 911 | 1,206 | $406,487 | $93,774 |
| 2022 | 11 | 889 | 1,234 | $412,381 | $100,500 |
| 2021 | 12 | 868 | 1,271 | $414,112 | $109,546 |
| 2020 | 12 | 907 | 1,198 | $362,769 | $88,253 |
Total Patients
3,575
Total Services
4,909
Medicare Billing
$392,073
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 369 | $144,648 | $32,469 | 22.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 40 | 40 | $61,520 | $14,585 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 103 | $56,753 | $13,535 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $37,960 | $8,517 | 22.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 33 | 66 | $25,410 | $6,424 | 25.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 29 | 116 | $14,304 | $4,767 | 33.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 25 | 26 | $24,856 | $4,083 | 16.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 69 | 73 | $16,571 | $3,805 | 23.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 271 | 295 | $15,930 | $3,173 | 19.9% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 15 | 15 | $5,505 | $1,692 | 30.7% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 20 | 30 | $3,030 | $724.14 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 287 | 421 | $162,416 | $36,438 | 22.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 41 | 41 | $63,058 | $15,979 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 92 | $49,732 | $12,718 | 25.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 39 | 78 | $29,224 | $7,653 | 26.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 33 | 132 | $15,836 | $6,371 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $25,480 | $5,859 | 23.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 30 | 30 | $21,216 | $4,687 | 22.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 72 | 82 | $18,614 | $4,353 | 23.4% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2022 | 30 | 30 | $11,010 | $3,495 | 31.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 238 | 262 | $14,148 | $2,661 | 18.8% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 12 | 17 | $1,647 | $288.06 | 17.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 298 | 481 | $170,391 | $44,156 | 25.9% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 57 | 57 | $87,666 | $23,551 | 26.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2021 | 47 | 94 | $34,968 | $9,232 | 26.4% |
About Dr. John Cava, MD
Dr. John Cava, MD is a Cardiovascular Disease healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245290675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Cava, MD has received a total of $57,223 in payments from pharmaceutical and medical device companies, with $80.47 received in 2023. These payments were reported across 265 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($49,089).
As a Medicare-enrolled provider, Cava has provided services to 3,575 Medicare beneficiaries, totaling 4,909 services with total Medicare billing of $392,073. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Providence, RI
- Active Since 03/28/2006
- Last Updated 04/21/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1245290675
Products in Payments
- Repatha (Biological) $21,376
- PRALUENT ALIROCUMAB INJECTION (Biological) $14,658
- PRALUENT (Drug) $14,089
- PRALUENT (Biological) $3,985
- XARELTO (Drug) $766.35
- ENTRESTO (Drug) $393.51
- Corlanor (Drug) $350.61
- ELIQUIS (Drug) $317.93
- PRADAXA (Drug) $215.96
- CHANTIX (Drug) $161.60
- FARXIGA (Drug) $125.00
- Kerendia (Drug) $80.47
- JARDIANCE (Drug) $75.09
- Veltassa (Drug) $63.89
- KYNAMRO (Drug) $56.15
- Lexiscan (Drug) $41.43
- BYSTOLIC (Drug) $41.22
- Accessories (Structural Intervention) (Device) $40.62
- BRILINTA (Drug) $27.52
- Livalo (Drug) $25.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Providence
Mrs. Jinnette Abbott, Md, MD
Cardiovascular Disease — Payments: $153,138
Cardiovascular Disease $153,138
Ara Sadaniantz, Md, MD
Cardiovascular Disease — Payments: $84,120
Cardiovascular Disease $84,120
Dr. Carlos Cuello
Cardiovascular Disease — Payments: $19,646
Cardiovascular Disease $19,646
Dr. Franklin Schneider, Md, MD
Cardiovascular Disease — Payments: $15,467
Cardiovascular Disease $15,467
Jeremy Lum, Md, MD
Cardiovascular Disease — Payments: $12,810
Cardiovascular Disease $12,810
Paul Gordon, Md, MD
Cardiovascular Disease — Payments: $12,436
Cardiovascular Disease $12,436